Tu1790 COMBINATION BIOLOGIC OR SMALL MOLECULE THERAPY IN INFLAMMATORY BOWEL DISEASE
Catherine McShane, David Kevans(Mount Sinai Hospital), Hugh Mulcahy(University College Dublin), Karen Boland(Beaumont Hospital), C Smyth, Glen Doherty(University College Dublin), Orlaith Kelly, John R. Campion, Karen Hartery(St. James's Hospital), Eoin Slattery(University Hospital Galway), Susan McKiernan, Deirdre McNamara(Trinity College Dublin), Clodagh Byron, Alan Marrinan, Barry Hall, Anne Fennessy, Martin Buckley(Mercy University Hospital), Eabha Ring, Stephen Patchett, Laurence J. Egan(Health Service Executive), Jane McCarthy(Mercy University Hospital), Subrata Ghosh(University College Cork), Juliette Sheridan(St. Vincent's University Hospital), Carthage Moran(University College Cork), J Leyden, Rachel Varley, Donal Sheehan(University of Vienna), Aoibhlinn O’Toole, Áine Keogh, A. M. O'Sullivan(Tallaght University Hospital), Conor Palmer, Karl Hazel, Richard J. Farrell(Beth Israel Deaconess Medical Center), Cara Dunne
Cited by 0
Related Papers
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
|Journal of Crohn s and Colitis|2019|1.4k
Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
|New England Journal of Medicine|2012|1.1k
ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment
|Journal of Crohn s and Colitis|2019|1.1k
ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment
|Journal of Crohn s and Colitis|2021|1.1k